Delivery Order SPE2DB20D1100-SPE2DB25FE0U0
Award Date 8/14/25
Potential Completion Date 8/15/25
Potential Value $32K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order valued at $4,970.25 to AmerisourceBergen Drug Corp for the supply of Dupixent 300 mg/2 ml syringes on June 18, 2025, with an ultimate completion date of June 20, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and represents a single delivery transaction under AmerisourceBergen's existing pharmaceutical supply framework. The place of performance is listed as Conshohocken, Pennsylvania, where...
- The Defense Logistics Agency awarded a delivery order valued at $131,333.75 to AmerisourceBergen Drug Corp for the supply of Dupixent 300 mg/2 ml syringes on July 29, 2025, with an ultimate completion date of July 30, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and is classified as a child contract under AmerisourceBergen's larger pharmaceutical supply agreement with DLA. The product will be delivered to the company's corporate office location in...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $8,957.42 to AmerisourceBergen Drug Corp on September 9, 2025, for the supply of Dupixent 300 mg/2 mL syringes. This non-competitive delivery order, with a firm fixed price structure, represents a child contract against AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The product will be delivered to AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $11,735.46 to AmerisourceBergen Drug Corp for the supply of Dupixent 300 mg/2 ml syringes on July 30, 2025, with an ultimate completion date of July 31, 2025. This is a firm fixed price, competitively awarded contract with no set-aside designation. The order will be fulfilled from AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters and serves as a major pharmaceutical...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $31,867.64 to AmerisourceBergen Drug Corp on August 26, 2025, for the supply of Dupixent (dupilumab) 300 mg/2 mL syringes. This contract represents a firm fixed-price delivery order with an ultimate completion date of August 27, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award was made on a competitive, non-set-aside basis, reflecting AmerisourceBergen's established capability...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 10, 2025, for the supply of Dupixent 300 mg/2 ml syringes with a ceiling value of $57,859.44 under a Firm Fixed Price contract type. This is a non-set-aside award, reflecting AmerisourceBergen's demonstrated capability to compete for federal pharmaceutical procurement requirements. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $29,250.86 on September 12, 2025, for the supply of Dupixent 300 mg/2 ml syringes with a completion date of September 15, 2025. This is a firm fixed price delivery order with no set-aside designation, competitively awarded to the Conshohocken, Pennsylvania-based pharmaceutical distributor. The contract is performed at AmerisourceBergen's corporate office location in Conshohocken. This delivery order is...
- The Defense Logistics Agency awarded a delivery order valued at $45,274.14 to AmerisourceBergen Drug Corp for the supply of Dupixent (dupilumab) 300 mg/2 mL syringes on August 27, 2025, with a completion date of August 28, 2025. This contract utilizes a firm fixed-price delivery order structure with no set-aside designation, indicating competitive award through open procurement channels. The pharmaceutical product will be delivered to AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 14, 2025, for the supply of Dupixent 300 mg/2 ml syringes with a ceiling value of $15,257.22 under a firm fixed-price contract. This is a non-set-aside competitive award with an ultimate completion date of July 15, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as the prime contractor and will fulfill this order from its corporate office location. This delivery order falls...
- The Defense Logistics Agency awarded a delivery order valued at $14,743.07 to AmerisourceBergen Drug Corp for the supply of Dupixent 200 mg/1.14 mL syringes on September 5, 2025, with completion scheduled for September 8, 2025. The contract is a firm fixed price delivery order with no set-aside designation, indicating competitive award based on capability demonstration. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, fulfilled the order from its Corporate Office...